Paper28322941
Small-Dosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1 and ABCG2), and Interaction (Atorvastatin and Grapefruit Juice) Profiles of 5 Probes for OATP2B1 and BCRP.
Kashihara Y and 11 others. J Pharm Sci, 2017. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Small-Dosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1 and ABCG2), and Interaction (Atorvastatin and Grapefruit Juice) Profiles of 5 Probes for OATP2B1 and BCRP. Papers, record 28322941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28322941
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Small-Dosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1 and ABCG2), and Interaction (Atorvastatin and Grapefruit Juice) Profiles of 5 Probes for OATP2B1 and BCRP.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ATP Binding Cassette Transporter, Subfamily G, Member 2 | Major topic |
| Atorvastatin | Major topic |
| Citrus paradisi | Major topic |
| Organic Anion Transporters | Major topic |
| Pharmacogenetics | Major topic |
| ATP Binding Cassette Transporter, Subfamily B | |
| Adult | |
| Celiprolol | |
| Dose-Response Relationship, Drug | |
| Drug Interactions | |
| Female | |
| Food-Drug Interactions | |
| Genotype | |
| Glyburide | |
| Humans | |
| Intestinal Absorption | |
| Male | |
| Neoplasm Proteins | |
| Rosuvastatin Calcium | |
| Sulfasalazine | |
| Sumatriptan |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41390976 | Repeated Intake of Grapefruit Juice Inhibits CYP2B6, CYP2C9, CYP2C19, and CYP3A4 while Lingonberry Powder Does Not Induce Major CYP Enzymes in Humans. | Clin Pharmacol Ther | 2026 | https://conductscience.org/library/papers/41390976 | PubMed |
| 41011221 | Dietary Modulation of CYP3A4 and Its Impact on Statins and Antidiabetic Drugs: A Narrative Review. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41011221 | PubMed |
| 40838969 | The pharmacogenetics of rosuvastatin and implications for treatment: a systematic review. | Pharmacogenomics | 2025 | https://conductscience.org/library/papers/40838969 | PubMed |
| 37623137 | Safety Concerns Related to the Simultaneous Use of Prescription or Over-the-Counter Medications and Herbal Medicinal Products: Survey Results among Latvian Citizens. | Int J Environ Res Public Health | 2023 | https://conductscience.org/library/papers/37623137 | PubMed |
| 37191827 | Inhibition Effect of Okanin Toward Human Cytochrome P450 3A4 and 2D6 with Multi-spectroscopic Studies and Molecular Docking. | J Fluoresc | 2024 | https://conductscience.org/library/papers/37191827 | PubMed |
| 34594217 | Organic Anion Transporting Polypeptide 2B1 (OATP2B1) Genetic Variants: In Vitro Functional Characterization and Association With Circulating Concentrations of Endogenous Substrates. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34594217 | PubMed |
| 33403255 | Contribution of Uptake and Efflux Transporters to Oral Pharmacokinetics of Furosemide. | ACS Omega | 2020 | https://conductscience.org/library/papers/33403255 | PubMed |
| 32483763 | Investigation of Fluorescent Substrates and Substrate-Dependent Interactions of a Drug Transporter Organic Anion Transporting Polypeptide 2B1 (OATP2B1). | Pharm Res | 2020 | https://conductscience.org/library/papers/32483763 | PubMed |
| 32114507 | Role of Oatp2b1 in Drug Absorption and Drug-Drug Interactions. | Drug Metab Dispos | 2020 | https://conductscience.org/library/papers/32114507 | PubMed |
| 31719649 | Pharmacokinetic parameters of ifosfamide in mouse pre-administered with grapefruit juice or naringin. | Sci Rep | 2019 | https://conductscience.org/library/papers/31719649 | PubMed |
| 31628668 | Dose-Dependent Inhibition of OATP1B by Rifampicin in Healthy Volunteers: Comprehensive Evaluation of Candidate Biomarkers and OATP1B Probe Drugs. | Clin Pharmacol Ther | 2020 | https://conductscience.org/library/papers/31628668 | PubMed |
| 31590349 | Transporters in the Mammary Gland-Contribution to Presence of Nutrients and Drugs into Milk. | Nutrients | 2019 | https://conductscience.org/library/papers/31590349 | PubMed |
| 31188698 | Effects of Ginkgo leaf tablets on the pharmacokinetics of atovastatin in rats. | Pharm Biol | 2019 | https://conductscience.org/library/papers/31188698 | PubMed |
| 30563187 | ATP-Binding Cassette Transporters in the Clinical Implementation of Pharmacogenetics. | J Pers Med | 2018 | https://conductscience.org/library/papers/30563187 | PubMed |
| 29322864 | Effects of Danshen tablets on pharmacokinetics of atorvastatin calcium in rats and its potential mechanism. | Pharm Biol | 2018 | https://conductscience.org/library/papers/29322864 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCA4 | 24 | PubTator's text mining | https://conductscience.org/library/genes/24 | NCBI Gene |
| ABCG2 | 9429 | PubTator's text mining | https://conductscience.org/library/genes/9429 | NCBI Gene |
| SLCO2B1 | 11309 | PubTator's text mining | https://conductscience.org/library/genes/11309 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28322941
GET https://conductscience.org/api/papers/v1/28322941/authors